1-5 of 5
Ignacio Wistuba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A24: Targeted synthetic lethal screens to identify acquired vulnerabilities in a novel class of ASCL1-dependent neuroendocrine non-small cell lung cancers

Alexander Augustyn, Mark Borromeo, Tao Wang, Chunli Shao, Patrick Dospoy, Kenneth Huffman, Ryan Carstens, Luc Girard, Carmen Behrens, Ignacio Wistuba, Yang Xie, Jane Johnson, Adi Gazdar, John Minna
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (5_Supplement): A24.
https://doi.org/10.1158/1535-7163.PMS-A24
Published: 01 May 2014
View article titled, Abstract A24: Targeted synthetic lethal screens to identify acquired vulnerabilities in a novel class of ASCL1-dependent neuroendocrine non-small cell lung cancers
Journal Articles

Abstract B50: Regulation of non-small cell lung cancer stem cells by STAT3 and WNT pathways.

Chunli Shao, Chris DeSevo, Luc Girard, Paul Yenerall, Carmen Behrens, Ignacio Wistuba, John D. Minna
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B50.
https://doi.org/10.1158/1535-7163.TARG-13-B50
Published: 01 November 2013
View article titled, Abstract B50: Regulation of non-small cell lung cancer stem cells by STAT3 and WNT pathways.
Journal Articles

A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras

Yanan Yang, Marie Wislez, Nobukazu Fujimoto, Ludmila Prudkin, Julie G. Izzo, Futoshi Uno, Lin Ji, Amy E. Hanna, Robert R. Langley, Diane Liu, Faye M. Johnson, Ignacio Wistuba, Jonathan M. Kurie
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (4): 952–960.
https://doi.org/10.1158/1535-7163.MCT-07-2045
Published: 15 April 2008
View article titled, A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant <em>K-ras</em>
Open the PDF for A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant <em>K-ras</em> in another window
Journal Articles

Angiogenesis in non-small cell lung cancer (NSCLC): Gender differences in tumor and circulating angiogenic factors

Emer Hanrahan, Ludmila Prudkin, Heather Yan Lin, Carmen Behrens, Erminia Massarelli, Matthew Herynk, Danny Du, Marie Wislez, Jonathan Kurie, Roy Herbst, J. Jack Lee, Ignacio Wistuba, John Heymach
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): A24.
Published: 01 November 2007
View article titled, Angiogenesis in non-small cell lung cancer (NSCLC): Gender differences in tumor and circulating angiogenic factors
Journal Articles

Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion

Anne S. Tsao, Dandan He, Babita Saigal, Suyu Liu, J. Jack Lee, Srinivasa Bakkannagari, Nelson G. Ordonez, Waun Ki Hong, Ignacio Wistuba, Faye M. Johnson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (7): 1962–1972.
https://doi.org/10.1158/1535-7163.MCT-07-0052
Published: 09 July 2007
View article titled, Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion
Open the PDF for Inhibition of c-Src expression and activation in malignant pleural mesothelioma tissues leads to apoptosis, cell cycle arrest, and decreased migration and invasion in another window